Therapy device for instilling fluid to a tissue site

专利摘要:
THERAPY DEVICE FOR INSTALLING FLUID TO A TISSUE SITE; SOLUTION CARTRIDGE FOR AN INSTALLATION THERAPY DEVICE; THERAPY DEVICE TO TREAT A TISSUE SITE; AND; APPLIANCES, SYSTEMS AND METHODS. It is a therapy device (104) for instilling fluid to a tissue site. The therapy device includes a base that has a cartridge receptacle (122) and a bracket (120) attached to the base to secure the base to a rod. The therapy device also includes a cartridge (112) configured to engage the base when positioned in the cartridge receptacle. The therapy device also includes a pump head (128) disposed within the cartridge receptacle and configured to engage the cartridge to move fluid. The cartridge includes a body that forms at least a portion of a fluid reservoir, and a tube segment coupled to the body and in fluid communication with the fluid reservoir. The tube segment is configured to engage the pump head.
公开号:BR112015011666B1
申请号:R112015011666-3
申请日:2013-11-22
公开日:2022-01-25
发明作者:Aidan Marcus Tout；Kenneth Smith；Thomas Paul Lawhorn
申请人:3M Innovative Properties Company；
IPC主号:

专利说明:

Pursuant to Title 35, Paragraph 119(e), of the United States code, this application claims priority and benefit from Provisional Patent Application No. System for use with a Negative Pressure Treatment System”, the disclosure of which is incorporated herein by reference in its entirety. FIELD OF TECHNIQUE
[001] The present disclosure relates generally to medical treatment systems for treating tissue sites that produce fluids, such as exudate, and for processing body fluids. More particularly, but without limitation, the present disclosure relates to a system for volumetric delivery of solution with a therapy device. BACKGROUND
[002] Clinical studies and practice have shown that reducing pressure in proximity to a tissue site can enhance and accelerate new tissue growth at the tissue site. The applications of this phenomenon are numerous, but it has proven to be particularly advantageous for treating wounds. Regardless of the etiology of an injury, whether trauma, surgery, or other cause, proper wound care is important to the outcome. The treatment of reduced pressure wounds may be commonly referred to as "reduced pressure therapy", but is also known by other names, including "negative pressure therapy", "negative pressure wound therapy", "vacuum therapy" and " vacuum assisted closing”, for example. Reduced pressure therapy can provide a number of benefits, including migration of epithelial and subcutaneous tissues, improved blood flow, and tissue microdeformation at a wound site. Together, these benefits can increase granulation tissue development and shorten healing times.
[003] In addition, delivery of therapeutic fluids, such as antibiotic or saline fluids, to the tissue site may also provide healing benefits to the tissue site. The treatment of tissue sites with the delivery of therapeutic fluids can be termed "instillation therapy". Instillation therapy can assist in cleansing the tissue site by aiding in the removal of infectious agents or necrotic tissue. Therapeutic fluids used in instillation therapy may also include medicinal fluids, such as antibiotics, antifungals, antiseptics, analgesics, or other similar substances, to aid in the treatment of a tissue site.
[004] While the clinical benefits of reduced pressure therapy and instillation therapy are well known, the cost and complexity of reduced pressure therapy and instillation therapy may be a limiting factor in their application, development and operation. of reduced pressure systems, components and processes continue to present significant challenges to manufacturers, healthcare professionals and patients. SUMMARY OF ILLUSTRATIVE MODALITIES
[005] In accordance with an illustrative embodiment, a therapy device for instilling fluid to a tissue site is described. The therapy device may include a base that has a cartridge receptacle and a bracket attached to the base for securing the base to a rod. The therapy device may also include a cartridge configured to engage the base when positioned in the cartridge receptacle. The therapy device may additionally include a pump head disposed within the cartridge receptacle and configured to engage the cartridge for fluid movement.
[006] According to another illustrative embodiment, a solution cartridge for an instillation therapy device is described. The cartridge may include a body that forms at least a portion of a fluid reservoir. A fill port may be fluidly coupled to the fluid reservoir and configured to receive fluid. A heat seal can be attached to the fill port. The solution cartridge may include a tube segment coupled to the body and in fluid communication with the fluid reservoir. The tube segment may be configured to engage a pump head of a therapy device for movement of fluid from the fluid reservoir.
[007] According to yet another exemplary embodiment, a solution cartridge for an instillation therapy device is described. The solution cartridge may include a body that forms at least a portion of a fluid reservoir. The body may be oval in shape with a rounded end and a flattened end opposite the rounded end. The body may include a fill port fluidly coupled to the fluid reservoir and configured to receive fluid and a plug coupled to the fill port. The solution cartridge may also include a tube segment coupled to the body and in fluid communication with the fluid reservoir. The tube segment may be configured to engage a pump head of a therapy device for movement of fluid from the fluid reservoir.
[008] According to yet another embodiment, a solution cartridge for an instillation therapy device is described. The solution cartridge includes a carrier that has a base housing and a tube housing. The solution cartridge also includes a fluid container that has a port configured to engage the base housing. The solution cartridge may additionally include a tube segment disposed in the tube housing and coupled to the carrier. The tube segment may be configured to be in fluid communication with the fluid container and to engage a pump head of a therapy device for movement of fluid from the fluid container.
[009] In accordance with yet another exemplary embodiment, a therapy device for treating a tissue site is described. The therapy device may include a solution cartridge that has a fluid reservoir, an adductor channel and a tube suspended through the adductor channel. The therapy device may also include a cartridge receptacle adapted to receive the solution cartridge. The therapy device may additionally include a rotating delivery pump head disposed within the cartridge receptacle. The rotating delivery pump head may have a circumferential edge and lobes coupled to the circumferential edge. The circumferential edge may be adapted to press the tube into the raceway and the lobes are adapted to cyclically engage the tube into the raceway.
[010] Other aspects, features and advantages of the illustrative embodiments will become apparent with reference to the drawings and the detailed description that follow. BRIEF DESCRIPTION OF THE DRAWINGS
[011] Figure 1 is a functional block diagram of an exemplary modality of a therapy system that can regulate therapeutic pressure and/or provide instillation solution in accordance with this specification;
[012] Figure 2 is a perspective view of a therapy device with a solution cartridge installed in accordance with an illustrative embodiment;
[013] Figure 3 is a side elevation of the therapy device of Figure 2 with the solution cartridge installed;
[014] Figure 4 is a perspective view of a portion of the therapy device of Figure 2 that has the solution cartridge removed;
[015] Figure 5 is a perspective view of the solution cartridge of Figure 2;
[016] Figure 6 is a side elevation of the solution cartridge of Figure 5;
[017] Figure 7 is a side elevation of another solution cartridge installed in a therapy device;
[018] Figure 8 is a perspective view of the solution cartridge of Figure 7;
[019] Figure 9A is a sectional view of the solution cartridge of Figure 8 taken along the line 9A-9A of Figure 8;
[020] Figure 9B is a sectional view of the solution cartridge of Figure 8 taken along the line 9B-9B of Figure 8;
[021] Figure 9C is a sectional view of another exemplary embodiment of the solution cartridge of Figure 8 taken along line 9B-9B of Figure 8;
[022] Figure 9D is a plan view of a port of the solution cartridge of Figure 8;
[023] Figure 10 is a side elevation of the therapy device of Figure 7 which has the solution cartridge removed;
[024] Figure 11 is an exploded view of another exemplary embodiment of a solution cartridge;
[025] Figure 12 and Figure 13 are sectional views of a portion of a port of the solution cartridge of Figure 11 that has a vent tip disposed therein;
[026] Figure 14 is a plan view of a port plug of Figure 12 and Figure 13;
[027] Figure 15 is a side elevation of an exemplary embodiment of a therapy device that can be used with the solution cartridge of Figure 11;
[028] Figure 16 is an exploded view of another exemplary embodiment of a solution cartridge lid of Figure 11;
[029] Figure 17 is a side elevation of another embodiment of a solution cartridge;
[030] Figure 18 is a rear elevation of the solution cartridge of Figure 17;
[031] Figure 19 is a sectional view of the solution cartridge of Figure 18 taken along line 19-19;
[032] Figure 20 is a side elevation of a therapy device that can be used with the fluid container of Figure 17; and
[033] Figure 21 is a partial frontal elevation of the therapy device of Figure 20. DETAILED DESCRIPTION OF ILLUSTRATIVE MODALITIES
[034] New and useful systems, methods and apparatus for providing a combined solution pump and solution storage system for treating a tissue site are set out in the appended claims. Objects, advantages and a preferred way of producing and using the systems, methods and apparatus can be understood with reference to the following detailed description in conjunction with the accompanying drawings. The description provides information enabling a person skilled in the art to produce and use the claimed subject matter, but may omit certain details already well known in the art. Furthermore, descriptions of various alternatives using terms such as “or” do not necessarily require mutual exclusivity unless clearly required by the context. The claimed subject matter may also encompass alternative embodiments, variations and equivalents not specifically described in detail. The following detailed description should therefore be considered illustrative and not limiting.
[035] Exemplary modalities may also be described herein in the context of reduced pressure therapy and instillation therapy applications, but many of the features and advantages are readily applicable to other environments and industries. The spatial relationships between various elements or the spatial orientation of various elements can be described as shown in the accompanying drawings. In general, such relationships or guidelines assume a frame of reference consistent with or relative to a patient in a position to receive reduced pressure therapy. However, as will be recognized by those skilled in the art, this frame of reference is merely a descriptive device rather than a strict prescription.
[036] Figure 1 is a simplified functional block diagram illustrating details that may be associated with some modalities of a therapy system 100. In some modalities, the therapy system 100 may provide therapeutic pressure and/or instillation in accordance with this descriptive report. In some embodiments, the therapy system 100 may include a sheath 102 fluidly coupled to a therapy device 104. The sheath 102 may include a cloth, such as a cloth 108, and a tissue interface, such as a tubing 110. Therapy system 100 may also include a fluid container, such as a container 112, and/or a solution cartridge, such as a cartridge 114. The container 112 may be fluidly coupled between the housing 102 and the therapy device. 104. Cartridge 114 may be fluidly coupled to casing 102 and operatively coupled to therapy device 104.
[037] In general, the components of the therapy system 100 may be directly or indirectly coupled to each other. For example, therapy device 104 may be directly coupled to container 112 and indirectly coupled to casing 102 via container 112. The components may be fluidly coupled to one another to provide a path for transferring fluids (i.e., liquid and /or gas) between the components. In some embodiments, the components may be fluidly coupled with a tube, for example. A "tube" as used herein refers broadly to a tube, pipe, hose, conduit or other structure with one or more lumina adapted to carry fluid between two ends. Typically, a tube is an elongated cylindrical structure with some flexibility, but geometry and rigidity can vary. In some embodiments, the components may additionally or alternatively be coupled by virtue of physical proximity, being integral to a single structure, or being formed from the same piece of material. Coupling can also include mechanical, thermal, electrical, or chemical bonding (such as a chemical bond) in some contexts.
[038] During operation, a tissue interface, such as tubing 110, may be placed within a tissue location, over, in, against, or otherwise adjacent to, a tissue location. For example, the tubing 110 can be placed against a fabric location, and the cloth 108 can be placed over the tubing 110 and sealed to the fabric near the fabric location. Tissue near a tissue site is normally undamaged epidermis peripheral to the tissue site. In this way, the sheath 102 can provide a sealed therapeutic environment close to a tissue site, substantially isolated from the external environment, and the therapy device 104 can reduce pressure on the sealed therapeutic environment. The reduced pressure can be distributed across the tissue interface through the tissue site in the sealed therapeutic environment to induce macrostrain and microstrain as well as remove exudates and other fluids from a tissue site, which can be collected in container 112 and disposed of in an orderly manner. appropriate.
[039] Exudates may refer to a fluid that filters from the circulatory system in lesions or areas of inflammation. Exudates may include water and dissolved solutes. Dissolved solutes can include blood, plasma proteins, white blood cells, platelets and red blood cells. In some embodiments, exudates may include serum, fibrin, and white blood cells. In other embodiments, exudates may include pus that has a thin, protein-rich fluid and dead white blood cells.
[040] The fluid mechanics of using a source of reduced pressure to reduce pressure on another component or location, such as within a sealed therapeutic environment, can be mathematically complex. However, the basic principles of fluid mechanics applicable to reduced pressure therapy are generally well known to those skilled in the art, and the process of reducing pressure may be illustratively described herein as "delivery", "delivery ” or “generation” of reduced pressure, for example.
[041] In general, exudates and other fluids flow toward lower pressure along a fluid path. Thus, in the context of reduced pressure therapy, the term “downstream” typically suggests something in a fluid path relatively closer to a source of reduced pressure, and conversely, the term “upstream” implies something relatively closer. away from a source of reduced pressure. Similarly, it may be convenient to describe certain features in terms of fluid “input” or “output” in such a frame of reference. Such guidance is provided, in general, for purposes of describing various features and components of reduced pressure therapy systems herein. However, the fluid trajectory can also be reversed in some applications (such as replacing a source of positive pressure with a source of reduced pressure) and this descriptive convention should not be interpreted as a limiting convention.
[042] The term “tissue site” in this context refers broadly to an injury or defect located in or within tissue, including, but not limited to, bone tissue, adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons or ligaments. A wound can include chronic, acute, traumatic, subacute and open wounds from dehiscence, partial thickness burns, ulcers (such as diabetic, pressure or venous insufficiency ulcers), flaps and grafts, for example. The term "tissue site" can also refer to areas of any tissue that are not necessarily injured or defective, but are instead areas where it may be desirable to add or promote the growth of additional tissue. For example, reduced pressure can be used on certain areas of tissue to develop additional tissue that can be harvested and transplanted to another tissue location.
[043] “Reduced pressure” generally refers to a pressure less than a local ambient pressure, such as ambient pressure in a local environment outside of a sealed therapeutic environment provided by the 102 liner. In many cases, the local ambient pressure can also be the atmospheric pressure at which a patient is located. Alternatively, the pressure may be less than a hydrostatic pressure associated with tissue at the tissue site. Unless otherwise indicated, pressure values set forth herein are gauge pressures. Similarly, references to increases in reduced pressure typically refer to a decrease in absolute pressure, while decreases in reduced pressure typically refer to an increase in absolute pressure.
[044] The therapy device 104 may include a source of reduced pressure. A source of reduced pressure can be a reservoir of air at a reduced pressure, or it can be a handheld or electrically powered device that can reduce pressure in a sealed volume, such as a vacuum pump, a suction pump, a suction port. wall pump available in many healthcare facilities or a micropump, for example. A source of reduced pressure may be housed within components or used in conjunction with other components, such as sensors, processing units, alarm indicators, memory, databases, software, display devices, or user interfaces that further facilitate therapy. by reduced pressure. Although the amount and nature of reduced pressure applied to a tissue site may vary according to therapeutic requirements, the pressure typically ranges between -5 mm Hg (-667 Pa) and -500 mm Hg (-66.7 kPa) . Common therapeutic ranges are between -75 mm Hg (-9.9 kPa) and -300 mm Hg (-39.9 kPa).
[045] The therapy device 104 may also include a source of fluid. A fluid source can be a reservoir of fluid at atmospheric pressure or greater, or it can be a handheld or electrically powered device, such as a pump, that can transport fluid into a sealed volume, such as a sealed therapeutic environment, for example. In some embodiments, a fluid source may be a peristaltic pump. A peristaltic pump may include a circular pump housing that has an impeller with one or more rollers. In some embodiments, a rotor can also be called a pump head, and rollers can also be called shoes, lugs, or lobes, for example. The rollers can be clamped around a circumference of the rotor and positioned close to a section of pipe. A peristaltic pump may additionally include a motor coupled to the rotor and configured to rotate the rotor so that the rollers engage the tube section. As each roller engages the tube, it may compress a portion of the tube, occluding the compressed portion of the tube. Rotating the rotor can move the compressed location of the tube, pushing fluid through the tube ahead of the roller. Also, as the tube opens after a roller passes, fluid can be drawn into the tube behind the roller. In this way, fluid can be drawn into the tube and moved therethrough. In general, the tubes engaged by a roller of a peristaltic pump can be formed of silicone.
[046] A fluid source may be housed within components or used in conjunction with other components such as sensors, processing units, alarm indicators, memory, databases, software, display devices or user interfaces that facilitate additionally instillation therapy. The amount and nature of fluid applied to a tissue site may vary according to therapeutic requirements, which may include the size of the sealed therapeutic environment, the type of fluid, and any additives to the fluid. In some embodiments, the fluid may include: hypochlorite-based solutions, such as hypochlorous acid and sodium hypochlorite; silver nitrate; sulfur-based solutions such as sulfonamides; biguanides, such as polyhexanide; cationic solutions such as octenidine and benzalkonium chloride; and isotonic solutions.
[047] Therapy device 104 may also include a user interface. A user interface may be a device configured to allow communication between a controller and an environment external to the therapy device 104. In some embodiments, an external environment may include an operator or a computer system configured to interface with the therapy device. 104, for example. In some embodiments, a user interface may receive a signal from a controller and present the signal in a way that can be understood by an external environment. In some embodiments, a user interface can receive signals from an external environment and, in response, send signals to a controller.
[048] In some embodiments, a user interface may be a graphical user interface, a touch screen, or one or more motion tracking devices. A user interface may also include one or more display screens, such as a liquid crystal display ("LCD"), lighting devices, such as light-emitting diodes ("LEDs") of various colors, and audible indicators, such as a whistle, configured to emit a sound that can be heard by an operator. A user interface may additionally include one or more devices, such as handles, buttons, keyboards, remote controls, touch screens, ports that can be configured to receive a discrete or continuous signal from another device or other similar devices; these devices can be configured to allow the external environment to interact with the user interface. A user interface may allow an external environment to select a therapy to be performed with the therapy device 104. In some embodiments, a user interface may display information to an external environment such as a therapy duration, a therapy type, an amount of reduced pressure being supplied, an amount of instillation solution being supplied, a fluid level from a container or a fluid level from a cartridge, for example.
[049] Therapy device 104 may also include one or more pressure sensors. A pressure sensor can be a piezoresistive strain gauge, a capacitive sensor, an electromagnetic sensor, a piezoelectric sensor, an optical sensor or a potentiometric sensor, for example. In some embodiments, a pressure sensor can measure a voltage caused by applied pressure. A pressure sensor can be calibrated by relating a known amount of voltage to a known applied pressure. The known relationship can be used to determine an unknown applied pressure based on a measured amount of stress. In some embodiments, a pressure sensor may include a receptacle configured to receive applied pressure.
[050] Therapy device 104 may also include one or more valves. In some embodiments, for example, a valve may be fluidly coupled between a fluid reservoir and the liner 102. A valve may be a device configured to selectively allow fluid flow through the valve. A valve may be a ball valve, a slide valve, a butterfly valve, or another type of valve that can be operated to prevent or allow fluid flow through the valve. In general, a valve may include a valve body having a flow passage, a valve member disposed in the flow passage and operable to selectively block the flow passage, and an actuator configured to operate the valve member. . An actuator may be configured to position the valve member in a closed position, preventing fluid flow through the valve's fluid passage; an open position, which allows fluid flow through the valve's fluid passage; or a metering position, which allows fluid flow through the valve's flow passage at a selected flow rate. In some embodiments, the actuator may be a mechanical actuator configured to be operated by an operator. In some embodiments, the actuator may be an electromechanical actuator configured to operate in response to receiving an input signal. For example, the actuator may include an electric motor configured to receive a signal from a controller. In response to the signal, the actuator's electric motor can move the valve member of the valve. In some embodiments, a valve may be configured to selectively allow fluid communication between the therapy device 104 and the housing 102.
[051] The therapy device 104 may also include one or more flow meters. A flow meter can be a device configured to measure a fluid flow rate. A flowmeter may include a mechanical flowmeter, a pressure-based flowmeter, an optical flowmeter, an open channel flowmeter, a thermal mass flowmeter, a swirl flowmeter, electromagnetic flow meters, ultrasonic flow meters and Coriolis flow meters and laser doppler flow meters. The flow meter can determine a rate of fluid flow through the valve and transmit a signal to a controller that corresponds to the determined flow rate.
[052] Therapy device 104 may also include one or more controllers communicatively coupled to components of therapy device 104, such as a valve, flow meter, sensor, user interface, or pump, for example. , to control its operation. As used herein, communicative coupling may refer to a coupling between components that allows for the transmission of signals between the components. In some embodiments, the signals may be discrete or continuous signals. A discrete signal can be a signal that represents a value in a particular case over a period of time. A plurality of discrete signals can be used to represent a value of change over a period of time. A continuous signal can be a signal that provides a value for each case over a period of time. The signals can also be analog signals or digital signals. An analog signal can be a continuous signal that includes a time-varying feature that represents another amount of time-varying. A digital signal can be a signal composed of a sequence of discrete values.
[053] In some embodiments, the communicative coupling between a controller and other devices may be one-way communication. In one-way communication, signals can only be sent in one direction. For example, a sensor may generate a signal that can be communicated to a controller, but the controller may not have the ability to send a signal to the sensor. In some embodiments, the communicative coupling between a controller and another device may be two-way communication. In two-way communication, signals can be sent in both directions. For example, a controller and a user interface can be communicatively coupled so that the controller can send and receive signals from the user interface. Similarly, a user interface can send and receive signals from a controller. In some embodiments, signal transmission between a controller and another device may be referred to as the controller operating the device. For example, the interaction between a controller and a valve can be referred to as the controller: operating the valve; placing the valve in an open position, a closed position or a metering position; or opening the valve, closing the valve or measuring the valve.
[054] A controller can be a computing device or system, such as a programmable logic controller or a data processing system, for example. In some embodiments, a controller can be configured to receive input from one or more devices, such as a user interface, a sensor, or a flow meter, for example. In some embodiments, a controller may receive input, such as an electrical signal, from an alternate source, such as through an electrical gate, for example.
[055] In some embodiments, a controller may be a data processing system. A data processing system suitable for storing and/or executing program code may include at least one processor coupled directly or indirectly to memory elements via a system bus. Memory elements can include local memory employed during actual program code execution, mass storage, and cache memories that provide temporary storage of at least some program code in order to reduce the number of times code is retrieved from storage in mass during execution.
[056] In some embodiments, a controller may be a programmable logic controller (PLC). A PLC can be a digital computer configured to receive one or more inputs and send one or more outputs in response to one or more inputs. A PLC may include non-volatile memory configured to store programs or operating instructions. In some embodiments, the non-volatile memory may be operationally coupled to a battery backup so that the non-volatile memory retains programs or operating instructions if the PLC otherwise loses power. In some embodiments, a PLC can be configured to receive both discrete and continuous signals and produce both discrete and continuous signals in response.
[057] Therapy device 104 may also include a power source. A power source can be a device that supplies electrical power to an electrical load. A power source may include a battery, a direct current (DC) power supply, an alternating current (AC) power supply, a linearly regulated power supply, or a switched mode power supply, for example. . A power supply can supply electrical power to a controller, sensor, flow meter, valve, user interface, or pump, for example.
[058] A tissue interface, such as tubing 110, can generally be adapted to contact a tissue site. A tissue interface may be partially or completely in contact with a tissue site. If a tissue site is a wound, for example, a tissue interface may partially or completely fill the wound or may be placed over the wound. A tissue interface can take many shapes and can be many sizes, shapes or thicknesses depending on a variety of factors, such as the type of treatment being implanted or the nature and size of a tissue site. For example, the size and shape of a tissue interface can be adapted to the contours of deep, irregularly shaped tissue sites.
[059] In general, a tubing, such as tubing 110, for example, is a substance or structure adapted to distribute or remove fluids through a tissue site. A pipeline may include flow channels or pathways that provide multiple openings that distribute fluid supplied to and removed from a tissue location around the pipeline. In an illustrative embodiment, the flow channels or trajectories may be interconnected to improve uniformity of distribution of fluids delivered to or removed from a tissue site. For example, open cell foam, collections of porous fabric and other porous material such as gauze or felt cloth generally include structural elements arranged to form flow channels. Liquids, gels and other foams may also include or be cured to include flow channels.
[060] In an illustrative embodiment, the tubing 110 may be a porous foam pad that has interconnected cells adapted to distribute reduced pressure across a tissue site. The foam can be either hydrophobic or hydrophilic. In a non-limiting example, the tubing 110 can be an open cell, cross-linked polyurethane foam, such as GranuFoam® coating available from Kinetic Concepts, Inc. of San Antonio, Texas.
[061] In an example in which the tubing 110 may be made of a hydrophilic material, the tubing 110 can also draw fluid away from a tissue site, while continuing to distribute reduced pressure across the tissue site. The wicking properties of tubing 110 can remove fluid away from a tissue site through capillary flow or other wicking mechanisms. An example of a hydrophilic foam is an open cell polyvinyl alcohol foam, such as the V.A.C. WhiteFoam® available from Kinetic Concepts, Inc. of San Antonio, Texas. Other hydrophilic foams may include those made from polyether. Other foams that may exhibit hydrophilic characteristics include hydrophobic foams that have been treated or coated to provide hydrophilicity.
[062] A tissue interface can further promote granulation to a tissue site when the pressure within the sealed therapeutic environment is reduced. For example, any or all of the surfaces of tubing 110 can have an irregular, coarse, or rough profile that can induce micro-strains and stresses at a tissue location if reduced pressure is applied through tubing 110.
[063] In one embodiment, a tissue interface may be constructed from bioresorbable materials. Suitable bioresorbable materials may include, without limitation, a polymer blend of polylactic acid (PLA) and polyglycolic acid (PGA). The polymer blend may also include, without limitation, polycarbonates, polyfumarates and capralactones. The tissue interface may additionally serve as a scaffold for new cell growth, or a scaffold material may be used in conjunction with a tissue interface to promote cell growth. A scaffold is generally a biodegradable or biocompatible substance or structure used to enhance or promote cell growth or tissue formation, such as a three-dimensional porous structure that provides a template for cell growth. Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxyapatites, carbonates or processed allograft materials.
[064] Cloth 108 is an example of a sealing member. A sealing member may be constructed from a material that can provide a fluid seal between two components or two environments, such as between a therapeutic environment and a local external environment. A sealing member may be, for example, an impermeable or semipermeable elastomeric film, which may provide a seal suitable for maintaining reduced pressure at a tissue location for a given source of reduced pressure. For semipermeable materials, the gas permeability should, in general, be low enough that a desired reduced pressure can be maintained. An attachment device may be used to secure a sealing member to an attachment surface, such as undamaged epidermis, a gasket, or other sealing member. A fixture can take many forms. For example, a fastening device may be a medically acceptable pressure sensitive adhesive that extends around a periphery, a portion or an entire sealing member. Other exemplary embodiments of an attachment device may include a double-sided tape, paste, hydrocolloid, hydrogel, silicone gel, organogel, or an acrylic adhesive.
[065] A "container", such as container 112, broadly includes a can, bag, bottle, vial or other fluid collection apparatus. Container 112, for example, can be used to manage exudates and other fluids removed from a tissue site. In some embodiments, container 112 may include substances to manage fluid in container 112, such as insulators or absorbents, for example. In many environments, a rigid container may be preferred or required to collect, store and dispose of fluids. In other environments, fluids can be disposed of properly without rigid container storage, and a reusable container can reduce residual waste and costs associated with reduced pressure therapy.
[066] A "cartridge", such as cartridge 114, is representative of another container, can, bag or other storage component, which may be used to manage fluids, such as instillation solution, which may be supplied to the place of fabric. In many environments, a rigid container may be preferred or required to deliver, store and dispense the instillation solution. In other environments, the instillation solution may be provided in a non-rigid container. A reusable container can reduce residual waste and costs associated with instillation.
[067] In general, reduced pressure therapy can be beneficial for injuries of all severity, but the cost and complexity of reduced pressure therapy systems typically limit the application of reduced pressure therapy to large, high exuding wounds present in patients. undergoing acute or chronic care, as well as other severe injuries that are not readily susceptible to healing without the application of reduced pressure. The instillation of a fluid to a wound may additionally aid in the healing of a wound. Instillation may include slowly introducing a solution into the wound, for example. The solution can be used to provide moisture to the wound, provide heat or cold to the wound, deliver a drug to the wound, or deliver another substance to the wound. Often, each type of instillation therapy may require a different type of instillation fluid to achieve a desired effect. For example, a first type of fluid can provide moisture to the wound. A different type of fluid can deliver a drug to the wound. Often, the need for different types of fluid to treat the wound can make instillation therapy time consuming to administer.
[068] Some patients may experience improved outcomes with a combination treatment that includes using both reduced pressure therapy and instillation therapy. Existing therapy systems that provide tissue site instillation or irrigation as well as reduced pressure therapy can be cumbersome to use and configure. Multiple tubes, fasteners and interfaces may normally be required to properly apply both reduced pressure and fluid to the tissue site. For example, to configure a therapy system that has both reduced pressure therapy and instillation therapy, components for both systems can be placed in close proximity to a patient. The reduced pressure therapy portion may need at least one set of tubing that extends from the tissue site to the therapy system. In addition, a floor space near the patient may be occupied by a separate collection container which may also require a separate tubing set that extends between the tissue site and/or therapy device.
[069] The instillation therapy system may require at least one rod for intravenous administration to be placed in close proximity to the patient. Another rod for intravenous administration may be needed to support additional therapy devices. At least one IV bag, and usually multiple, can be suspended from the IV pole. Each pouch suspended from the intravenous delivery rod may contain a different type of instillation fluid to apply a particular type of instillation fluid to the tissue site to achieve a desired effect. Each bag may require a separate tubing set that connects the bag to the therapy device and from the therapy device to the tissue site. Each bag may also need fasteners and valves for each tube set. As multiple bags, tubing assemblies, fasteners and valves are added to the therapy system, complexity increases. The increased complexity increases setup time for a healthcare professional and increases the likelihood that the healthcare professional administering therapy may incorrectly administer therapy.
[070] As disclosed herein, the therapy system 100 can overcome these and other shortcomings by providing a solution storage system and combined solution pump. In addition, therapy device 104 can place all components pertinent to volumetric fluid delivery in a single disposable assembly. The disposable set may interface with the therapy device 104 automatically if the disposable set engages with the therapy device 104.
[071] Figure 2 is a perspective view of therapy device 104 illustrating details that may be associated with some modalities. Therapy device 104 may have a base member, such as a body 116, a user interface panel, such as a panel 118, and a rod holder, such as a bracket 120. The body 116 may be a housing, container or other member configured to enclose components of therapy device 104. In some embodiments, body 116 may have an interior space in which pumps, tubing, valves, electronics, controllers, regulators, measurement devices or sensors, for example, may be contained. The devices may be similar to that described above and operate as described above to provide reduced pressure therapy and/or instillation therapy. The body 116 may also include a handle 115. The handle 115 may be a portion of the body 116 configured to allow a healthcare professional to hold and carry the therapy device 104.
[072] In some embodiments, therapy device 104 may include cartridge 114 and canister 112. Both canister 112 and cartridge 114 may be inserted into therapy device 104. In some embodiments, canister 112 and cartridge 114 may be placed in a front portion of therapy device 104. As shown in Figure 2, therapy device 104 may include a tube 107 and a coupling 123. Tube 107 may protrude from a front of the therapy device 104 next to cartridge 114. Coupling 123 may be fluidly coupled to tube 107.
[073] Figure 3 is a side view of therapy device 104 illustrating additional details that may be associated with some modalities. The bracket 120 may be a device configured to mount the therapy device 104 to a bracket, an intravenous delivery rod, or other device. In some embodiments, bracket 120 may be configured to mount to an intravenous delivery rod, such as a rod 119, for example. The bracket 120 may include a gripper 121. In some embodiments, the gripper 121 may be a threaded screw that has a handle. The screw may be screwed into the bracket 120 so that one end of the threaded screw of the gripper 121 can be pressed against the shank 119. The gripper 121 can compress the stem 119 against the bracket 120, preventing the bracket 120 and therapy device 104 to move with respect to stem 119. In other embodiments, bracket 120 may include other devices for securing therapy device 104 to stem 119, such as locking mechanisms, linkage mechanisms, or fusion mechanisms, for example example.
[074] Figure 4 is a perspective view of therapy device 104 illustrating additional details that may be associated with some modalities. As shown, cartridge 114 has been removed from therapy device 104. In some embodiments, therapy device 104 may include a cartridge receptacle 122. Cartridge receptacle 122 may be a cavity or other recessed portion of therapy device 104. Cartridge receptacle 122 may be extended to body 116 from a front of body 116. In some embodiments, cartridge receptacle 122 may have at least a bottom surface 127, a back surface 131, and a side surface 133 In some embodiments, the bottom surface 127, the back surface 131 and the side surface 133 are perpendicular to each other. In some embodiments, cartridge receptacle 122 may be configured to receive cartridge 114. For example, cartridge receptacle 122 may be sized and shaped such that cartridge 114 can, at least partially, fit within cartridge receptacle. 122. In some embodiments, the cartridge 114 and cartridge receptacle 122 may be sized so that, if the cartridge 114 is inserted into the cartridge receptacle 122, an exterior surface of the cartridge 114 can be flush with an exterior portion of the cartridge. therapy 104 as shown in Figure 2 and Figure 3.
[075] Referring to Figure 4, in some embodiments, a key 124 may be positioned within the cartridge receptacle 122 on the side surface 133. In some embodiments, the key 124 may be disposed near a center of a height of the side surface 133. The key 124 may have a length equal to the length of the side surface 133 so that the key 124 extends from the front of the therapy device 104 to the rear surface 131. In some embodiments, the key 124 may protrude from side surface 133 of cartridge receptacle 122. In some embodiments, key 124 may also include an opening 126. Opening 126 may be configured to receive a mating component of cartridge 114, such as a closure, for example. In other embodiments, the pairing component can be a pipe component, a vent component, a pickup component, or a pump component, for example.
[076] In some embodiments, a pumphead 128 may be positioned within the cartridge receptacle 122. The pumphead 128 may be positioned on the side surface 133 between the bottom surface 127 and the keyway 124. In some embodiments, the pump head 128 may be a rotary delivery pump head that has a rotor with one or more rollers 129. As described above, rollers 129 may be configured to engage a tube segment to move fluid through the tube segment with the use of peristalsis. Pump head 128 may be coupled to operating components disposed within body 116 of therapy device 104. In some embodiments, operating components may include motors, linkages or power supplies, for example. Pump head 128 and associated operating components may be disposed within body 116 of therapy device 104 and may be operatively or communicatively coupled to panel 118. In some embodiments, panel 118 may be manipulated by a healthcare professional to activate pumphead 128, causing pumphead 128 to rotate in a plane parallel to side surface 133. As described above, rotation of pumphead 128 can move instillation solution from cartridge 114 to the location of fabric.
[077] Figure 5 is a perspective view of the cartridge 114 that illustrates additional details that may be associated with some embodiments. Figure 6 is a side elevation of cartridge 114 in Figure 5. Cartridge 114 may include a lock 113. Lock 113 may be a recessed portion of cartridge 114. In some embodiments, lock 113 may be a slot or channel that has a shape configured to receive key 124 from cartridge receptacle 122. In some embodiments, lock 113 may have a pentagonal shape to match key 124. Lock 113 may extend from a front 109 of cartridge 114 to a back 111 of the cartridge 114.
[078] The cartridge 114 may also include a tube housing 117. The tube housing 117 may be a recessed portion of the cartridge 114 that extends from the back 111 of the cartridge 114 towards the front 109 of the cartridge 111. Tube housing 117 may be a generally rectangular shaped recess that has a rounded end proximate the front 109 of cartridge 114. The rounded end of tube housing 117 may be shaped to accommodate tube 107. Tube 107 may have a end 105 fluidly coupled to an interior of cartridge 114. Tube 107 may also have an elbow 103. In some embodiments, elbow 103 may be a U-shaped elbow. In some embodiments, tube housing 117 may be shaped to receive pumphead 128. If cartridge 114 is inserted into cartridge receptacle 122, pumphead 128 may engage tube 107 and be operable to compress tube 107 against housing. tube assembly 117 for peristaltic movement of fluid through tube 107.
[079] In some embodiments, the cartridge 114 may also include a tube channel 134. The tube channel 134 may be another recessed portion of the cartridge 114 that may be positioned between the tube housing 117 and a bottom of the cartridge 114. In In some embodiments, the tube channel 134 may extend from the front 109 of the cartridge 114 to the back 111 of the cartridge 114. The tube channel 134 may be configured to accommodate at least a portion of a tube, such as the tube. 107. In some embodiments, the elbow 103 can turn the tube 107 so that the tube 107 can be routed from the tube housing 117 to the tube channel 134 and protrudes from the front 109 of the cartridge 114. In some In embodiments, tube 107 may be fluidly coupled to a joint, such as coupling 123, for example. Coupling 123 may be a device configured to fluidly couple tube 107 to the tissue site. For example, coupling 123 may be configured to be fluidly coupled to a tube that is fluidly coupled to the tissue site.
[080] During an operation, cartridge 114 can be inserted into therapy device 104. If cartridge 114 is inserted into cartridge receptacle 122, key 124 and lock 113 can be aligned so that key 124 can be inserted in lock 113. Alignment of key 124 and lock 113 can align tube housing 117 and pump head 128. Pump head 128 can engage tube 107 if cartridge 114 is fully seated in cartridge receptacle 122 of therapy device 104. Operation of pump head 128 may move fluid through tube 107 from an interior of cartridge 114 through coupling 123.
[081] Figure 7 is an elevation view of a cartridge 214 that illustrates details that can be associated with some modalities. Cartridge 214 may be configured to engage a therapy device, for example, a therapy device 204. In some embodiments, therapy device 204 may resemble and include components of therapy device 104. Therapy device 204 may be configured to receive cartridge 214. For example, therapy device 204 may include a protrusion 232 configured to hold cartridge 214 and one or more retainers 234 configured to limit lateral motion of cartridge 214. In In some embodiments, the cartridge 214 may include a fluid container 215 and a carrier 216. In general, the fluid container 215 may interface with the carrier 216. The carrier 216 may interface with the therapy device 204 to secure the container. of fluid 215 in therapy device 204 to provide therapy for instillation. In some embodiments, carrier 216 may be an integral component of therapy device 204. In other embodiments, carrier 216 may be an independent component of therapy device 204.
[082] Figure 8 is a perspective view of the cartridge 214 that illustrates additional details that may be associated with some embodiments. In some embodiments, the fluid container 215 may be a container configured to receive and store a fluid, such as an instillation fluid. In some embodiments, the fluid container 215 can be a bottle or other refillable device. In some embodiments, fluid container 215 may be a prefabricated fluid container configured to engage conveyor 216. Fluid container 215 may have an open end and a closed end (not shown) opposite the open end. The open end of the fluid container 215 may be configured to receive a plug, coupling or other similar device. In some embodiments, the fluid container 215 may have a port 218 coupled to the open end of the fluid container 215. The port 218 may be a device coupled to the open end of the fluid container 215 and configured to be selectively open. In some embodiments, port 218 may include a seal, such as a seal 217. Seal 217 may be a device configured to seal fluid container 215 to another device or component. Seal 217 may be formed of a material, such as a rubber or other material configured to prevent fluid from flowing through seal 217. In some embodiments, seal 217 may be an O-ring. In some embodiments, seal 217 may be detached from one end of port 218. In other embodiments, seal 217 may be proximate to one end of port 218.
[083] The carrier 216 may include a base housing 220 and a tube housing 226. The base housing 220 may be a rectangular body that has a receptacle 222 and a vent tip 224 disposed in the receptacle 222. The receptacle 222 may be a recess disposed at a center of base housing 220 that extends from a top of base housing 220 toward a bottom of base housing 220. In the illustrated embodiment, receptacle 222 is cylindrical. In other embodiments, receptacle 222 can be of other sizes and shapes. Generally, receptacle 222 may have a size, shape, and depth configured to mate with port 218 so that port 218 fits within receptacle 222. Seal 217 may be configured to seal receptacle 222 if port 218 is disposed in receptacle 222. In other embodiments, receptacle 222 may be of a size, shape, and depth such that ports not specific to other fluid containers can be inserted into receptacle 222 to engage base housing 220 of conveyor 216.
[084] In some embodiments, the tube housing 226 may mate with the base housing 220. The tube housing 226 may be a C-channel shaped piece coupled to one side of the base housing 220. In some embodiments, the tube housing 226 may form a wall perpendicular to base housing 220 that extends forward beyond the surface of base housing 220 in which receptacle 222 is formed. An interior portion of the tube housing 226 may face away from the base housing 220. An upper end of the tube housing 226 may form an archway 211 between two side walls 213 of the channel-shaped piece. The inner portion can be arranged between the arch 211 and the two side walls 213 of the channel-shaped part. In some embodiments, tube housing 226 may have an open end opposite yoke 211.
[085] The inner portion of the tube housing 226 may be configured to receive a tube 228. The tube 228 may have a first end and a second end opposite the first end. The ends of the tube 228 may be near the open end of the tube housing 226. In some embodiments, the tube 228 may conform to the arch 211 of the tube housing 226. In some embodiments, the tube 228 may be in contact with the two side walls 213 and arch 211 of tube housing 226 along a length of tube 228. Tube 228 may be coupled to base housing 220 via elbow couplings 230. Elbow couplings 230 may be in fluid communication with receptacle 222 or vent tip 224 and tissue location.
[086] Figure 9A is a sectional view of the conveyor 216 that illustrates additional details that may be associated with some embodiments. As shown, an elbow 227 can be fluidly coupled to the elbow coupling 230 and tube 228. The elbow 227 can provide fluid coupling to another tube (not shown) that can be fluidly coupled to the tissue site. Fluid flowing from fluid container 215 to tube 228 in response to operation of therapy device 204 may flow through elbow coupling 230, elbow 227 and into the tissue site.
[087] Figure 9B is another sectional view of conveyor 216 that illustrates additional details that may be associated with some embodiments. Figure 9B may be a cross-sectional view of the conveyor 216 of Figure 9A. Base housing 220 may include a coupling cavity 229 that extends into base housing 220 from a surface opposite receptacle 222. In some embodiments, coupling cavity 229 may have a larger dimension, such as a diameter, which is greater than a major dimension of receptacle 222. In some embodiments, receptacle 222 and mating cavity 229 may be coaxial.
[088] In some embodiments, vent stub 224 may be disposed within receptacle 222. Vent stub 224 may extend outward from an interior surface of receptacle 222. In some embodiments, vent stub 224 may have a wider portion where the vent tip 224 joins a surface of the receptacle 222 and tapers into a narrower portion at a distal end of the vent tip 224. The vent tip 224 may be configured to penetrate the port 218 if port 218 of fluid container 215 is inserted into receptacle 222. For example, if fluid container 215 is inverted and fitted into receptacle 222 of base housing 220 and base housing 220 is secured to therapy device 204 , vent stub 224 may breach port 218. In some embodiments vent stub 224 may have a conduit 223. Conduit 223 may be in fluid communication with the cavity. and coupling 229. In some embodiments, the receptacle 222 may have a fluid passage 231 in fluid communication with an elbow 233. The elbow 233 may be fluidly coupled to the coupling 230 such that the elbow 233 is in fluid communication with tube 228. During operation, port 218 may be fitted to receptacle 222 so that vent tip 224 opens a gap in port 218 and conduit 223 can allow ambient air pressure to flow into fluid container 215. Vent tip 224 may form fluid paths at port 218 adjacent to vent tip 224. Fluid may flow from fluid container 215 through port 218 to receptacle 222 around vent tip 224. Fluid may flow through fluid passage 231 at elbow 233 and into tube 228 in response to operation of therapy device 204. Ambient air pressure may flow through conduit 223 to fluid container 215 in order to impair Prevent the formation of a vacuum in the fluid container 215 during operation of the therapy device 204.
[089] Figure 9C is a sectional view of conveyor 216 illustrating additional details that can be associated with other embodiments. In other embodiments, the conduit 223 of the vent tip 224 may be fluidly coupled to an elbow 225. The elbow 225 may be fluidly coupled to the elbow coupling 230 so that the elbow 225 can be in fluid communication with the tube 228. Operation of therapy device 204 may move fluid from fluid container 215 through conduit 223 of vent tip 224, through elbow 225 and elbow coupling 230 and into tube 228. In embodiments, vent tip 224 may include multiple lumens to allow both venting of fluid container 215 and flow of solution in fluid container 215 into therapy device 204.
[090] Figure 9D is a plan view of port 218 that illustrates additional details that can be associated with some modalities. Port 218 may include a channel 219. Channel 219 may be an area of port 218 configured so that a gap is opened by vent tip 224. In some embodiments, channel 219 may include break lines 221. rupture 221 may be portions of port 218 configured to open to fluid flow if vent tip 224 punctures channel 219. In some embodiments, rupture lines 221 may be perforations in port 218.
[091] Figure 10 is a side elevational view of therapy device 204 illustrating additional details that may be associated with some modalities. As shown, cartridge 214 has been removed from therapy device 204. In some embodiments, therapy device 204 may include a cartridge receptacle and a pump head. The cartridge receptacle may be formed by a ridge 232 and retainers 234. The ridge 232 may be a portion of the therapy device 204 that extends away from the therapy device 204. The ridge 232 may provide a location at which at least least a portion of cartridge 214 may be at rest while cartridge 214 is engaged with therapy device 204. Retainers 234 may be elongated portions of therapy device 204 that project from opposite sides of therapy device 204 Retainers 234 may limit lateral motion of cartridge 214 if cartridge 214 is engaged with therapy device 204. Pump head 236 may be a rotary delivery pump head similar to pump head 128 described above. Pump head 236 may include rollers or lobes 238 which may be configured to engage tube 228 if cartridge 214 is to be engaged with therapy device 204. Pump head 236 may be positioned relative to boss 232 so that, if cartridge 214 is engaged with therapy device 204, pump head 236 and lobes 238 engage with tube 228. During operation, pump head 236 may be rotated causing fluid to flow from the nozzle tip. vent 224 or receptacle 222 through tube 228 and into the fabric location.
[092] Figure 11 is an exploded view of a cartridge 314 that illustrates the details that can be associated with some modalities. Cartridge 314 may include a body 316 and a cap 318. The body 316 may be a rigid member that is rectangular in shape, as shown. In other embodiments, the body 316 may not be rigid and may have other shapes, such as triangular, circular, or amorphous shapes. In some embodiments, body 316 may have a back 317 and walls 319. Body 316 may have a fluid reservoir 320 formed by back 317 and walls 319. Lid 318 may confine fluid reservoir 320. In In some embodiments, fluid reservoir 320 may be configured to receive and store an instillation solution or other fluid for use with a therapy device, such as therapy device 104 or therapy device 204.
[093] The body 316 may include a port 322 in one of the walls 319 of the body 316. In some embodiments, the port 322 may be a tubular body that mounts to one of the walls 319. The port 322 may have a channel hub 323 that extends through wall 319 so that channel 323 is in fluid communication with fluid reservoir 320. A plug assembly 324 may be coupled to port 322. In some embodiments, plug assembly 324 may be a lip coupled to port 322 to provide a mounting surface for a plug 326. Plug 326 may be coupled to plug assembly 324 to prevent fluid communication through port 322. Plug 326 may be coupled to plug assembly 324 in followed by filling fluid reservoir 320. In some embodiments, plug 326 may be threaded, taped, or otherwise closed to plug assembly 324. In some embodiments, plug 326 may be a heat seal. A heat seal may be a plug welded to plug assembly 324 following filling fluid reservoir 320. Port 322, plug assembly 324, and plug 326 may allow a manufacturer or pharmacist to fill fluid reservoir 320 and then seals fluid reservoir 320 for transport.
[094] Cap 318 may be configured to be mounted to and sealed to body 316 to form fluid reservoir 320. Cap 318 may include a port 328. Port 328 may be a tubular body extending into the fluid reservoir 320 if cap 318 is mounted to body 316. Port 328 may include a channel 329 in fluid communication with fluid reservoir 320. In some embodiments, a vent plug 330 may be coupled to port 328. In some embodiments In other embodiments, a therapy device, such as therapy device 104 or therapy device 204, may include a vent tip 332. Vent plug 330 may block fluid flow through port 328 until cartridge 314 is removed. engaged with a therapy device.
[095] Lid 318 may also include a latch 336. Latch 336 may be arranged on lid 318 such that latch 336 is on an opposite side of lid 318 from fluid reservoir 320. Latch 336 may be configured to mate with a corresponding component in a therapy device, such as the key 124 of therapy device 104, for example. If the lock 336 fits with the corresponding component of a therapy device, the lock 336 secures the cartridge 314 to the therapy device. In this manner, cartridge 314 can be securely positioned in a therapy device while the therapy device pours an instillation solution or fluid from the fluid reservoir 320 to a tissue site.
[096] In some embodiments, a tube assembly 338 may be coupled to the cap 318. The tube assembly 338 may include a first assembly 340, a second assembly 342 and a tube 344. The first assembly 340 may be coupled to the cap 318 and includes one or more channels that provide a fluid path through cap 318. If cap 318 is mounted to body 316, the channels may be in fluid communication with fluid reservoir 320. A first shoulder 348 may be coupled to the first assembly 340. The first shoulder 348 may be a tubular body having a channel in fluid communication with the channels of the first assembly 340. The tube 344 may be a flexible tube having at least one lumen. The first shoulder 348 can be configured to be inserted into a first end of the tube 344 so that the tube 344 can be fluidly coupled to the first assembly 340. A retention collar 346 can be mounted on the tube 344. The retention collar 346 may be placed over the portion of the tube 344 into which the first shoulder 348 has been inserted. If the first shoulder 348 is inserted into the first end of the tube 344, the first end of the tube 344 can be expanded to accommodate the first shoulder 348. Thus, if the retaining collar 346 is placed over the portion of the tube 344 in which the first shoulder 348 has been inserted, retaining collar 346 can exert a frictional force on tube 344 which holds tube 344 at first shoulder 348.
[097] In some embodiments, the second assembly 342 may be coupled to the cover 318 and include one or more channels that provide a fluid path through the cover 318. If the cover 318 is mounted on the body 316, the channels may be in communication. fluid with the fluid reservoir 320. A second shoulder 350 may be coupled to the second assembly 342. The second shoulder 350 may be a tubular body having a channel in fluid communication with the channels of the second assembly 342. The second shoulder 350 may be configured to be inserted into a second end of the tube 344 so that the tube 344 can be fluidly coupled to the second assembly 342. A retaining collar 347 can be mounted on the tube 344. The retaining collar 347 can be placed over the portion of tube 344 into which second shoulder 350 has been inserted. If the second shoulder 350 is inserted into the second end of the tube 344, the second end of the tube 344 can be expanded to accommodate the second shoulder 350. Thus, if the retaining collar 347 is placed over the portion of the tube 344 in which the second shoulder 350 has been inserted, retaining collar 347 can exert a frictional force on tube 344 which holds tube 344 at second shoulder 350.
[098] The tube 344 may arcuate between the first assembly 340 and the second assembly 342 so that a pump head, such as the pump head 128 of the therapy device 104, can be disposed under the tube 344 in order to engage to tube 344. If actuated by a therapy device, pump head 128 may engage in peristalsis, as described above, to move fluid from fluid reservoir 320 through first assembly 340, tube 344, and second assembly 342 for communication fluid with a tissue site.
[099] The second assembly 342 may also include a valve connector 352. The valve connector 352 may be in fluid communication with the second assembly 342 and the tube 344 through the second shoulder 350. The valve connector 352 may be configured to receive a tube that is in fluid communication with the tissue site. In some embodiments, valve connector 352 may include a valve member that is positionable to selectively block fluid flow through valve connector 352. In some embodiments, valve connector 352 may be a check valve configured to allow fluid flow out of the second assembly 342 and to block fluid flow through the valve connector 352 into the second assembly 342.
[0100] The second assembly 342 may also include a pressure diaphragm 354 coupled to an outwardly facing portion of the second assembly 342. The pressure diaphragm 354 may be a device configured to engage a corresponding sensor in a therapy device. Pressure diaphragm 354 can communicate a pressure in the second assembly 342 with a therapy device. In some embodiments, a therapy device may receive a pressure signal from the pressure diaphragm 354 and, in response, adjust therapy.
[0101] Figure 12 is a sectional view of the vent tip 332 and port 328 illustrating additional details that may be associated with some embodiments. Vent tip 332 may have a tapered portion 333 and a base portion 335. The tapered portion 333 may have a central channel 337 extending through the tapered portion 333. The tapered portion 333 may be coupled to the base portion 335. The tapered portion 333 may have a wider portion adjacent the base portion 335. The tapered portion 333 may taper from the base portion 335 to a distal end. Conical portion 333 may be configured to penetrate vent plug 330 if vent plug 330 of cap 318 is placed near vent tip 332, for example if cartridge 314 is engaged with a therapy device.
[0102] The base portion 335 may be a tubular body generally having a central channel that has a filter 334 disposed within the channel. Filter 334 and center channel 337 may be in fluid communication so that fluid can flow through vent tip 332. Base portion 335 may include a first flange 339 and a second flange 341. First flange 339 may be tapered and extends away from vent stub 332. First flange 339 may be coupled to vent stub 332 adjacent a base of tapered portion 333. Second flange 341 may be coupled to a center of base portion 335. The second flange 341 may have a conical surface near the first flange 339 and a flat surface opposite the first flange 339.
[0103] In some embodiments, port 328 may include one or more holders. For example, port 328 may include a first detent 343 and a second detent 345. The first detent 343 may be an annular member disposed on an interior surface of the port 328 proximate the vent plug 330. The second detent 345 may also be a annular member disposed on the interior surface of port 328 between first detent 343 and an end of port 328 opposite vent plug 330.
[0104] Figure 13 is a sectional view of port 328 and vent tip 332 illustrating additional details that may be associated with some embodiments. As shown in Figure 13, the first flange 339 and the second flange 341 may be configured to engage the first detent 343 and the second detent 345 if the vent tip 332 is inserted into the port 328. In some embodiments, the tapered portion 333 may puncturing vent plug 330, allowing fluid communication through vent plug 330 through vent tip 332. In some embodiments, vent tip 332 may serve as a path for ambient air pressure flow in the fluid reservoir 320 to prevent a vacuum from forming in the fluid reservoir 320 during operation of the therapy device.
[0105] Figure 14 is a plan view of the vent plug 330 illustrating additional details that may be associated with some embodiments. The vent plug 330 may include a channel 331. In some embodiments, the channel 331 may form a cross that extends parallel to the respective diameters of the vent plug 330. The channel 331 may be aligned with the vent tip 332, if the vent tip 332 is disposed within port 328. Channel 331 may be a portion of vent plug 330 that is more susceptible to penetration than remaining portions of vent plug 330. In some embodiments, channel 331 may be a portion of the vent plug 330 that has a thickness that is less than one thickness of the remainder of the vent plug 330. In other embodiments, the channel 331 may be a portion of the vent plug 330 that has been treated to make the channel 331 more susceptible to damage. penetration compared to the remaining portions of vent plug 330.
[0106] Figure 15 is a side elevation view of a therapy device 304 illustrating additional details that may be associated with some modalities. As shown in Figure 15, vent tip 332 may be coupled to therapy device 304. In some embodiments, vent tip 332 may be positioned on therapy device 304 so that if cartridge 314 is engaged with therapy device 304, vent tip 332 may engage port 328. Therapy device 304 may also include wedge 370. Therapy device 304 may also include a recessed portion 372 that surrounds wedge 370. In some embodiments, the therapy device 304 recess 372 may be configured to receive at least a portion of lock 336 so that lock 336 and wedge 370 can engage each other if cartridge 314 is engaged with therapy device 304.
[0107] Therapy device 304 may also include a pumphead 374 that has one or more lobes 376. Pumphead 374 may be similar to pumphead 128 and operate as described above with respect to it and the pumphead. pump 236. Similarly, lobes 376 may be similar to rollers 129 and operate as described above with respect to them and lobes 238. In some embodiments, pump head 374 may be positioned on therapy device 304 so that the head pump 374 may engage with tube 344 if cartridge 314 is engaged with therapy device 304. Therapy device 304 may also include a pressure sensor 378. Pressure sensor 378 may be a sensor configured to engage the pressure diaphragm 354 in order to determine a pressure at the second assembly 342. In some embodiments, the therapy device 304 may include a sensor 380 and a sensor 382. Sensor 380 and sensor 382 may be positioned connected to the therapy device 304 to communicate with optional sensors that may be included in the cartridge 314.
[0108] Figure 16 is an exploded view of a cover 418 that illustrates the details that can be associated with some embodiments of the cartridge 314 of Figure 11. The cover 418 is similar to the cover 318 and may include the components thereof, modified as Described below. Lid 418 may include a port 428 similar to port 328. Port 428 may operate similarly to port 328. In some embodiments, port 428 may be configured to receive vent tip 332 as described above.
[0109] The cap 418 can also have a tube assembly 438. The tube assembly 438 can include a tube 450 and a plurality of couplings 440. The tube 450 can have a first end configured to pass through a hole 452 formed in the cap 418. In some embodiments, hole 452 may be positioned at one end of cap 418 proximate port 428. In some embodiments, hole 452 may be disposed in a recessed portion of cap end 418. In some embodiments, hole 452 can be sized to accommodate tube 450 while providing a seal to tube 450. In some embodiments, tube 450 can be in fluid communication with fluid reservoir 320 through hole 452 in cap 418. Tube 450 can be in fluid communication with fluid reservoir 320. include a segment (not shown) that extends from hole 452 to an end of cap 418 that is opposite hole 452 so that one end of tube 450 can be located at a bottom of fluid reservoir 320. Tube 450 may have a polyethylene liner. Lining the tube 450 with polyethylene can reduce reactions with the fluid stored in the fluid reservoir 320. In some embodiments, additional tubes can be lined with polyethylene.
[0110] Tube assembly 438 may also include a tube 444, an ultrasonic inspection segment 446, a cell load segment 448, and a tube 454. In some embodiments, the tube 450 is fluidly coupled to the load segment. load cell 448 with a coupling 440 so that fluid in tube 450 can flow to load cell segment 448. A load cell, such as load cell segment 448, can be a transducer that converts a force into a electrical signal. A force applied through a load cell can deform a strain gauge, changing the strain gauge's electrical resistance which can be interpreted by a controller or other device as an amount of applied force. In some embodiments, load cell segment 448 may be configured to communicate with a corresponding sensor on a therapy device. For example, in some embodiments, load cell segment 448 may communicate with sensor 380 or sensor 382 of therapy device 304. In some embodiments, load cell segment 448 may be configured to communicate with sensor 380, if cartridge 314, which has cap 418, is engaged with therapy device 304. If fluid flows through load cell segment 448, the fluid can exert a force on load cell segment 448 that can generate a corresponding signal at sensor 380. In this way, therapy device 304 can determine if there is fluid in fluid reservoir 320. In some embodiments, load cell segment 448 can also detect occlusion (blockage) situations.
[0111] The cell load segment 448 may be fluidly coupled to the tube 444 via another coupling 440. In some embodiments, the coupling 440 may be an elbow coupling, such as the coupling 440 between the load cell segment. cell 448 and tube 444. Tube 444 can be fluidly coupled to ultrasonic inspection segment 446 with yet another coupling 440. Tube 444 can be positioned to form an arc so that tube 444 can receive a pump head , such as pump head 374 of therapy device 304. If actuated by a therapy device 304, pump head 374 may engage in peristalsis to move fluid from fluid reservoir 320 through tube 444 to fluid communication with a tissue site as described above.
[0112] In some embodiments, the ultrasonic inspection segment 446 may be a device configured to use ultrasound to monitor the fluid reservoir 320. The ultrasonic inspection segment 446 may be configured to communicate with a therapy device, such as the therapy device 304. For example, if cartridge 314 having cap 418 is engaged with therapy device 304, ultrasonic inspection segment 446 may be in communication with sensor 382. Ultrasonic inspection segment 446 may also detect occlusion (blockages).
[0113] The ultrasonic inspection segment 446 can be fluidly coupled to another tube 454 with another coupling 440. The tube 454 can have a coupling at one end of the tube 454 as opposed to the ultrasonic inspection segment 446. In this way, the Tube 454 may be used to fluidly couple cartridge 314 having cap 418 to a cover and tissue site.
[0114] Cap 418 includes a recess 456 molded into cap 418. Recess 456 may be shaped to accommodate the connection of tube assembly 438 such that tube assembly 438 is veiled or at least partially recessed from an outer surface of the cap 418. A recessed portion 456 may be sized to receive a pump head, such as the pump head 374 of the therapy device 304 so that the outer surface of the cap 418 is veiled with the pump head 374 of the therapy device 304. therapy, if cartridge 314 is engaged with therapy device 304.
[0115] Figure 17 is an elevation of another exemplary embodiment of a cartridge 514 that may be used with a therapy device, such as therapy device 104, therapy device 204, or modified therapy device 304, as described below. Cartridge 514 may be similar in many respects to cartridge 114, cartridge 214, and cartridge 314. Cartridge 514 may include a shell 516. In some embodiments, shell 516 is at least partially ovoid in shape, has a rounded end and a flat end opposite the rounded end. In some embodiments, the rounded end is a lower end configured to engage a portion of a therapy device to at least partially secure cartridge 514 to the therapy device. The housing 516 may also include notches 521. The notches 521 may be recesses molded into a portion of the housing 516 near the flat end. Notches 521 may provide a handle portion configured to allow a person to pick up cartridge 514 for engagement with and disengagement from a therapy device.
[0116] In some embodiments, the shell 516 may include a hole 517 through the flat end of the shell 516. The hole 517 may provide fluid communication between an exterior of the cartridge 514 and an interior of the cartridge 514. The cartridge 514 may also include a port 522. In some illustrative embodiments, a filter may be disposed at port 522 to prevent bacteria, viruses, and other undesirable materials from entering cartridge 514.
[0117] In some embodiments, the cartridge 514 also has a tube assembly 538, which may be similar to the tube assembly 338 or the tube assembly 438. The tube assembly 538 may include suitable connectors, such as an elbow 540 and a tube 544. In some embodiments, the tube assembly 538 may be fluidly coupled to a conduit 508, which may be adapted for coupling to a cover. As illustrated, the tube 544 may extend through a trough 546. The tube assembly 538 is configured to engage a pump head of a therapy device so that the pump head can cause the instillation disposed within cartridge 514 flows through tube assembly 538 and conduit 508 to a tissue site as described above.
[0118] Figure 18 is an elevation of a second side of the 514 cartridge illustrating the additional details that may be associated with some embodiments. In some embodiments, trough 546 may be a cavity in housing 516 adapted to receive a circumferential edge of a rotating delivery pump head (not shown). In some embodiments, pit 546 may be a portion of an assembly 545. Assembly 545 may be a device coupled to housing 516 and configured to position tube assembly 538 to receive a pump head. Assembly 545 may also include a latch 506. Latch 506 may be positioned adjacent the flat end of housing 516. Latch 506 may be configured to engage a portion of a therapy device to secure cartridge 514 in the therapy device. .
[0119] Figure 19 is a cross-sectional view of the cartridge 514 that illustrates additional details that may be associated with some embodiments. Housing 516 may form a fluid reservoir 520, similar to cartridge fluid reservoir 114, fluid container 215, and fluid reservoir 320. In some embodiments, housing 516 may include mounting locations 523 configured to receive fasteners 527 to secure the housing 516 to the assembly 545. Fasteners 527 may seal the housing 516 to prevent leakage of fluid through the mounting locations 523.
[0120] Cartridge 514 can be positioned to engage and interact with a pump head. The trough 546 can be a semi-circular cavity, and the tube 544 can be suspended through the cavity. In more particular embodiments, pit 546 may be a cavity with an arc of about 180 degrees. For example, tube 544 and trough 546 may be aligned with a circumferential edge of a rotating delivery pump head and disposed thereon. In this way, the tube 544 is disposed between the trough 546 and the edge of a pump head. Tube 544 can be stretched and pressed into and against pit 546 by a pump head.
[0121] In some embodiments, the latch 506 may be a spring loaded mechanism configured to engage with a fitting component of a therapy device. In some embodiments, the fastener 506 may include buttoning mechanisms, threaded mechanisms, clip mechanisms, or friction friction mechanisms, for example. In some embodiments, the latch 506 may be disposed on the cartridge 514 and engage an engagement element, such as a notch, clip, or threaded coupling, for example, in a therapy device.
[0122] Figure 20 is a side elevation of a therapy device 504 illustrating details that may be associated with some modalities. Figure 21 is a partial front elevation of therapy device 504 illustrating additional details that may be associated with some modalities. Therapy device 504 may be similar to therapy device 104, therapy device 204, and therapy device 304, modified as described herein. Therapy device 504 may have exterior dimensions similar to the exterior dimensions of cartridge 514 near assembly 545. In some embodiments, if cartridge 514 is engaged with therapy device 504, the edges of therapy device 504 may be veiled with the edges. of the cartridge 514. In some embodiments, the therapy device 504 may include a recess 505. The recess 505 may be shaped to receive the assembly 545. In some embodiments, the recess 505 may include a counterpart to the lock 506 proximate to a flat end of therapy device 504 that is configured to engage latch 506.
[0123] In some embodiments, the therapy device 504 may also include a pumphead 507 that has one or more lobes 509. The pumphead 507 may be similar to the pumphead 128, the pumphead 236, and the pumphead 236. pump head 374. In some embodiments, pump head 507 may be oriented perpendicular to a plane containing a side surface of therapy device 504. In this manner, pump head 507 may protrude from recess 505 of therapy device 504. therapy 504.
[0124] During operation, therapy device 504 may rotate pumphead 507, and lobes 509 attached to the outer circumference of pumphead 507 may cyclically engage and compress tube 544. As the pump head 507 turns, the portion of the tube 544 under compression is occluded, which can force fluid through the tube 544. Additionally, as the tube 544 opens after a lobe 509 passes, the fluid can be drawn into tube 544 from fluid reservoir 520 through port 522 and elbow 540. Thus, in the illustrative embodiment of Figures 17 to 21, fluid may be drawn cyclically from a bottom portion of the fluid reservoir 520 and pumped up through tube assembly 538 into conduit 508.
[0125] The systems and methods described in this document can provide significant advantages, some of which have already been mentioned. For example, the Therapy System 100 minimizes application problems in clinical care settings by replacing irrigation bags and bottles suspended from IV poles. The system delivers the instillation solution through a solution cartridge that minimizes IV bags and the confusion associated with device placement and installation. In addition, the system can decrease the amount of time required to install and change cans. The system can also provide volumetric delivery of instillation solution (via a solution cartridge) with a negative wound therapy therapy device. Specifically, the system allows a rotary delivery pump (located on the device) to engage a disposable cartridge containing an instillation solution.
[0126] While certain non-limiting illustrative embodiments have been presented, it should be understood that various changes, substitutions, permutations and alterations may be made without departing from the scope of the appended claims. It will be noted that any feature that is described in connection with any modality may also be applicable to any other modality.
[0127] It will be understood that the benefits and advantages described above may relate to one modality or may relate to several modalities. It will also be understood that reference to "a" item refers to one or more of such items.
[0128] The steps of the methods described in this document may be performed in any suitable order or simultaneously when appropriate.
[0129] Where appropriate, features from any of the modalities described above may be combined with features from any of the modalities described to form additional examples that have comparable or different properties and that address the same or different problems.
[0130] It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The specification, examples and data above provide a complete description of the structure and use of exemplary embodiments of the invention. While various embodiments of the invention have been described above with some degree of particularity, or with reference to one or more individual embodiments, persons skilled in the art can make numerous changes to the disclosed embodiments without departing from the scope of the claims.

权利要求:
Claims (15)
[0001]
1. THERAPY DEVICE (104, 204, 304) FOR INSTALLING FLUID TO A TISSUE SITE, comprising: a base having a cartridge receptacle (122); a bracket attached to the base for attaching the base to a rod; a cartridge (114, 214, 314) separable from the base and configured to engage the base when positioned in the cartridge pocket (122), the cartridge comprising: a body (116) having a recessed recess therein, wherein the body (116) 116) and the recess form a portion of a fluid reservoir (320), a tube segment coupled to the body (116) and having a tube suspended across the trough, the tube in fluid communication with the fluid reservoir (320); and a pump head (128, 236, 374) having a roller (129) and having one or more lobes (238), disposed within the cartridge receptacle (122) and configured to engage the cartridge for moving fluid.
[0002]
A THERAPY DEVICE (104, 204, 304) as claimed in claim 1, further comprising a supply port fluidly coupled to the fluid reservoir (320) and configured to receive fluid.
[0003]
A THERAPY DEVICE (104, 204, 304) according to any one of claims 1 or 2, further comprising: a load cell segment (448) fluidly coupled to the tube segment between one end of the tube segment and the fluid reservoir (320); and a sensor (308) coupled to the base and configured to communicatively couple to the load cell segment (448) if the cartridge is disposed in the cartridge receptacle (122).
[0004]
A THERAPY DEVICE (104, 204, 304) according to any one of claims 1 to 3, further comprising: an ultrasonic inspection segment (446) fluidly coupled to the tube segment; and a sensor (308) coupled to the base and configured to communicatively couple to the ultrasonic inspection segment (446) if the cartridge is disposed in the cartridge receptacle (122).
[0005]
A THERAPY DEVICE (104, 204, 304) according to any one of claims 1 to 4, characterized in that the body (116) comprises a cap (318) configured to form a portion of the fluid reservoir (320) and the cap (318) has a recess configured to receive a portion of the tube segment and pump head (128, 236, 374).
[0006]
6. THERAPY DEVICE (104, 204, 304) according to any one of claims 1 to 5, characterized in that the body (116) has an ovoid shape with a rounded end and a flat end opposite the rounded end, the body (116) has one or more notches near the flat end.
[0007]
A THERAPY DEVICE (104, 204, 304) according to any one of claims 1 to 6, characterized in that the body (116) comprises a trough and the tube segment comprises a tube suspended through the trough.
[0008]
A THERAPY DEVICE (104, 204, 304) as claimed in claim 1, further comprising: a carrier (216) having a base housing (220) and a tube housing (226); a tube segment disposed in the tube housing (226); and a fluid container having a port configured to engage the base housing (220) to fluidly couple the fluid container to the tube segment.
[0009]
A THERAPY DEVICE (104, 204, 304) according to claim 8, characterized in that the base housing (220) further comprises: a rectangularly shaped body (116) having a receptacle (122) disposed in a top surface; and a venting spike (224) disposed in the receptacle (122).
[0010]
A THERAPY DEVICE (104, 204, 304) as claimed in claim 9, characterized in that the vent tip (224) is fluidly coupled to the tube segment.
[0011]
11. THERAPY DEVICE (104, 204, 304) according to claim 9, characterized in that: the vent tip (224) is fluidly coupled to an ambient air pressure; and the receptacle (122) includes a fluid passage in fluid communication with the tube segment.
[0012]
12. THERAPY DEVICE (104, 204, 304) according to claim 2, characterized in that it additionally comprises: a heat seal coupled to the supply port.
[0013]
A THERAPY DEVICE (104, 204, 304) as claimed in claim 1, characterized in that the body (116) comprises a cap (318) configured to form a portion of the fluid reservoir (320), the cap (318) the trough in the lid (318) and the trough is configured to receive a portion of the tube segment and the pump head (128, 236, 374) of the therapy device.
[0014]
A THERAPY DEVICE (104, 204, 304) according to claim 2, further comprising: a plug (324, 326, 330) coupled to the supply port.
[0015]
A THERAPY DEVICE (104, 204, 304) as claimed in claim 1, the pump head (128, 236, 374) comprises a rotating delivery pump head having a circumferential edge and lugs coupled to the circumferential edge. ; and wherein the circumferential edge is adapted to press the tube into the pit and the shoulders are adapted to cyclically engage the tube into the pit.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112015011666B1|2022-01-25|Therapy device for instilling fluid to a tissue site

---

US11266821B2|2022-03-08|Autonomous fluid instillation system and method with tissue site pressure monitoring

---

US20190022287A1|2019-01-24|Instillation Cartridge For Vacuum Actuated Fluid Delivery

---

US20190282740A1|2019-09-19|Disposable cartridge for vacuum actuated fluid delivery

---

US20110196278A1|2011-08-11|Adhesive film drape for use with negative pressure wound therapy device

同族专利:

---

公开号 | 公开日

---

JP6970865B2|2021-11-24|

---

CN104822401B|2019-03-08|

---

JP6612394B2|2019-11-27|

---

US20140163487A1|2014-06-12|

---

JP2020062385A|2020-04-23|

---

HK1211882A1|2016-06-03|

---

JP2018167053A|2018-11-01|

---

EP2922587B1|2019-09-04|

---

US10232155B2|2019-03-19|

---

EP3566730B1|2022-01-19|

---

AU2019204533A1|2019-07-18|

---

CA2891227A1|2014-05-30|

---

AU2018201782A1|2018-04-05|

---

AU2013347852A1|2015-05-28|

---

JP2016501587A|2016-01-21|

---

CN109701095A|2019-05-03|

---

BR112015011666A2|2019-12-03|

---

US20190160271A1|2019-05-30|

---

AU2013347852B2|2017-12-14|

---

CN104822401A|2015-08-05|

---

JP6424312B2|2018-11-21|

---

WO2014082003A1|2014-05-30|

---

KR102226847B1|2021-03-15|

---

EP3566730A1|2019-11-13|

---

CA2891227C|2021-01-19|

---

EP2922587A1|2015-09-30|

---

AU2019204533B2|2020-12-03|

---

AU2018201782B2|2019-04-04|

---

KR20150090171A|2015-08-05|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US1355846A|1920-02-06|1920-10-19|David A Rannells|Medical appliance|

---

US2547758A|1949-01-05|1951-04-03|Wilmer B Keeling|Instrument for treating the male urethra|

---

US2632443A|1949-04-18|1953-03-24|Eleanor P Lesher|Surgical dressing|

---

GB692578A|1949-09-13|1953-06-10|Minnesota Mining & Mfg|Improvements in or relating to drape sheets for surgical use|

---

US2682873A|1952-07-30|1954-07-06|Johnson & Johnson|General purpose protective dressing|

---

NL189176B|1956-07-13|1900-01-01|Hisamitsu Pharmaceutical Co|PLASTER BASED ON A SYNTHETIC RUBBER.|

---

US2969057A|1957-11-04|1961-01-24|Brady Co W H|Nematodic swab|

---

US3066672A|1960-09-27|1962-12-04|Jr William H Crosby|Method and apparatus for serial sampling of intestinal juice|

---

US3367332A|1965-08-27|1968-02-06|Gen Electric|Product and process for establishing a sterile area of skin|

---

US3520300A|1967-03-15|1970-07-14|Amp Inc|Surgical sponge and suction device|

---

US3568675A|1968-08-30|1971-03-09|Clyde B Harvey|Fistula and penetrating wound dressing|

---

US3682180A|1970-06-08|1972-08-08|Coilform Co Inc|Drain clip for surgical drain|

---

BE789293Q|1970-12-07|1973-01-15|Parke Davis & Co|MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS|

---

US3826254A|1973-02-26|1974-07-30|Verco Ind|Needle or catheter retaining appliance|

---

DE2527706A1|1975-06-21|1976-12-30|Hanfried Dr Med Weigand|DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET|

---

DE2640413C3|1976-09-08|1980-03-27|Richard Wolf Gmbh, 7134 Knittlingen|Catheter monitor|

---

NL7710909A|1976-10-08|1978-04-11|Smith & Nephew|COMPOSITE STRAPS.|

---

GB1562244A|1976-11-11|1980-03-05|Lock P M|Wound dressing materials|

---

US4080970A|1976-11-17|1978-03-28|Miller Thomas J|Post-operative combination dressing and internal drain tube with external shield and tube connector|

---

US4139004A|1977-02-17|1979-02-13|Gonzalez Jr Harry|Bandage apparatus for treating burns|

---

US4184510A|1977-03-15|1980-01-22|Fibra-Sonics, Inc.|Valued device for controlling vacuum in surgery|

---

US4165748A|1977-11-07|1979-08-28|Johnson Melissa C|Catheter tube holder|

---

US4256109A|1978-07-10|1981-03-17|Nichols Robert L|Shut off valve for medical suction apparatus|

---

SE414994B|1978-11-28|1980-09-01|Landstingens Inkopscentral|VENKATETERFORBAND|

---

GB2047543B|1978-12-06|1983-04-20|Svedman Paul|Device for treating tissues for example skin|

---

US4266545A|1979-04-06|1981-05-12|Moss James P|Portable suction device for collecting fluids from a closed wound|

---

US4284079A|1979-06-28|1981-08-18|Adair Edwin Lloyd|Method for applying a male incontinence device|

---

US4261363A|1979-11-09|1981-04-14|C. R. Bard, Inc.|Retention clips for body fluid drains|

---

US4569348A|1980-02-22|1986-02-11|Velcro Usa Inc.|Catheter tube holder strap|

---

EP0035583B1|1980-03-11|1985-08-14|Schmid, Eduard, Dr.Dr.med.|Skin graft pressure bandage|

---

US4297995A|1980-06-03|1981-11-03|Key Pharmaceuticals, Inc.|Bandage containing attachment post|

---

US4333468A|1980-08-18|1982-06-08|Geist Robert W|Mesentery tube holder apparatus|

---

US4465485A|1981-03-06|1984-08-14|Becton, Dickinson And Company|Suction canister with unitary shut-off valve and filter features|

---

US4392853A|1981-03-16|1983-07-12|Rudolph Muto|Sterile assembly for protecting and fastening an indwelling device|

---

US4373519A|1981-06-26|1983-02-15|Minnesota Mining And Manufacturing Company|Composite wound dressing|

---

US4392858A|1981-07-16|1983-07-12|Sherwood Medical Company|Wound drainage device|

---

US4419097A|1981-07-31|1983-12-06|Rexar Industries, Inc.|Attachment for catheter tube|

---

AU550575B2|1981-08-07|1986-03-27|Richard Christian Wright|Wound drainage device|

---

IL64001D0|1981-10-06|1982-01-31|Elmar Medical Systems Ltd|Blood treatment system|

---

SE429197B|1981-10-14|1983-08-22|Frese Nielsen|SAR TREATMENT DEVICE|

---

DE3146266A1|1981-11-21|1983-06-01|B. Braun Melsungen Ag, 3508 Melsungen|COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE|

---

US4551139A|1982-02-08|1985-11-05|Marion Laboratories, Inc.|Method and apparatus for burn wound treatment|

---

US4475909A|1982-05-06|1984-10-09|Eisenberg Melvin I|Male urinary device and method for applying the device|

---

EP0100148B1|1982-07-06|1986-01-08|Dow Corning Limited|Medical-surgical dressing and a process for the production thereof|

---

NZ206837A|1983-01-27|1986-08-08|Johnson & Johnson Prod Inc|Thin film adhesive dressing:backing material in three sections|

---

US4548202A|1983-06-20|1985-10-22|Ethicon, Inc.|Mesh tissue fasteners|

---

US4540412A|1983-07-14|1985-09-10|The Kendall Company|Device for moist heat therapy|

---

US4604089A|1983-08-15|1986-08-05|Codman & Shurtleff, Inc.|Pressure regulated irrigation system for arthroscopy|

---

US4543100A|1983-11-01|1985-09-24|Brodsky Stuart A|Catheter and drain tube retainer|

---

US4525374A|1984-02-27|1985-06-25|Manresa, Inc.|Treating hydrophobic filters to render them hydrophilic|

---

GB2157958A|1984-05-03|1985-11-06|Ernest Edward Austen Bedding|Ball game net support|

---

US4897081A|1984-05-25|1990-01-30|Thermedics Inc.|Percutaneous access device|

---

US5215522A|1984-07-23|1993-06-01|Ballard Medical Products|Single use medical aspirating device and method|

---

GB8419745D0|1984-08-02|1984-09-05|Smith & Nephew Ass|Wound dressing|

---

US4872450A|1984-08-17|1989-10-10|Austad Eric D|Wound dressing and method of forming same|

---

US4655754A|1984-11-09|1987-04-07|Stryker Corporation|Vacuum wound drainage system and lipids baffle therefor|

---

US4826494A|1984-11-09|1989-05-02|Stryker Corporation|Vacuum wound drainage system|

---

US4605399A|1984-12-04|1986-08-12|Complex, Inc.|Transdermal infusion device|

---

US5037397A|1985-05-03|1991-08-06|Medical Distributors, Inc.|Universal clamp|

---

US4640688A|1985-08-23|1987-02-03|Mentor Corporation|Urine collection catheter|

---

US4710165A|1985-09-16|1987-12-01|Mcneil Charles B|Wearable, variable rate suction/collection device|

---

US4758220A|1985-09-26|1988-07-19|Alcon Laboratories, Inc.|Surgical cassette proximity sensing and latching apparatus|

---

US4733659A|1986-01-17|1988-03-29|Seton Company|Foam bandage|

---

WO1987004626A1|1986-01-31|1987-08-13|Osmond, Roger, L., W.|Suction system for wound and gastro-intestinal drainage|

---

US4838883A|1986-03-07|1989-06-13|Nissho Corporation|Urine-collecting device|

---

JPH0333027B2|1986-05-29|1991-05-15|Terumo Corp|

---

GB8621884D0|1986-09-11|1986-10-15|Bard Ltd|Catheter applicator|

---

GB2195255B|1986-09-30|1991-05-01|Vacutec Uk Limited|Apparatus for vacuum treatment of an epidermal surface|

---

US4743232A|1986-10-06|1988-05-10|The Clinipad Corporation|Package assembly for plastic film bandage|

---

DE3634569A1|1986-10-10|1988-04-21|Sachse Hans E|CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS|

---

JPH0363913B2|1986-11-26|1991-10-03|Toshiro Tachibana|

---

GB8628564D0|1986-11-28|1987-01-07|Smiths Industries Plc|Anti-foaming agent suction apparatus|

---

GB8706116D0|1987-03-14|1987-04-15|Smith & Nephew Ass|Adhesive dressings|

---

US4787888A|1987-06-01|1988-11-29|University Of Connecticut|Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery |

---

US4863449A|1987-07-06|1989-09-05|Hollister Incorporated|Adhesive-lined elastic condom cathether|

---

US5176663A|1987-12-02|1993-01-05|Pal Svedman|Dressing having pad with compressibility limiting elements|

---

US4906240A|1988-02-01|1990-03-06|Matrix Medica, Inc.|Adhesive-faced porous absorbent sheet and method of making same|

---

US4985019A|1988-03-11|1991-01-15|Michelson Gary K|X-ray marker|

---

GB8812803D0|1988-05-28|1988-06-29|Smiths Industries Plc|Medico-surgical containers|

---

US4919654A|1988-08-03|1990-04-24|Kalt Medical Corporation|IV clamp with membrane|

---

US5000741A|1988-08-22|1991-03-19|Kalt Medical Corporation|Transparent tracheostomy tube dressing|

---

EP0379416B1|1989-01-16|1995-03-08|Roussel-Uclaf|Azabicycloheptene derivatives and their salts, process for their preparation, their use as medicaments and compositions containing them|

---

GB8906100D0|1989-03-16|1989-04-26|Smith & Nephew|Laminates|

---

US5527293A|1989-04-03|1996-06-18|Kinetic Concepts, Inc.|Fastening system and method|

---

US4969880A|1989-04-03|1990-11-13|Zamierowski David S|Wound dressing and treatment method|

---

US5100396A|1989-04-03|1992-03-31|Zamierowski David S|Fluidic connection system and method|

---

US5261893A|1989-04-03|1993-11-16|Zamierowski David S|Fastening system and method|

---

US5358494A|1989-07-11|1994-10-25|Svedman Paul|Irrigation dressing|

---

JP2719671B2|1989-07-11|1998-02-25|日本ゼオン株式会社|Wound dressing|

---

US5232453A|1989-07-14|1993-08-03|E. R. Squibb & Sons, Inc.|Catheter holder|

---

GB2235877A|1989-09-18|1991-03-20|Antonio Talluri|Closed wound suction apparatus|

---

US5134994A|1990-02-12|1992-08-04|Say Sam L|Field aspirator in a soft pack with externally mounted container|

---

US5092858A|1990-03-20|1992-03-03|Becton, Dickinson And Company|Liquid gelling agent distributor device|

---

JP2941918B2|1990-09-19|1999-08-30|テルモ株式会社|Weighing device|

---

US5149331A|1991-05-03|1992-09-22|Ariel Ferdman|Method and device for wound closure|

---

US5278100A|1991-11-08|1994-01-11|Micron Technology, Inc.|Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers|

---

US5636643A|1991-11-14|1997-06-10|Wake Forest University|Wound treatment employing reduced pressure|

---

US5645081A|1991-11-14|1997-07-08|Wake Forest University|Method of treating tissue damage and apparatus for same|

---

US5279550A|1991-12-19|1994-01-18|Gish Biomedical, Inc.|Orthopedic autotransfusion system|

---

US5267956A|1992-02-05|1993-12-07|Alcon Surgical, Inc.|Surgical cassette|

---

US5167613A|1992-03-23|1992-12-01|The Kendall Company|Composite vented wound dressing|

---

FR2690617B1|1992-04-29|1994-06-24|Cbh Textile|TRANSPARENT ADHESIVE DRESSING.|

---

DE4306478A1|1993-03-02|1994-09-08|Wolfgang Dr Wagner|Drainage device, in particular pleural drainage device, and drainage method|

---

US6241747B1|1993-05-03|2001-06-05|Quill Medical, Inc.|Barbed Bodily tissue connector|

---

US5342376A|1993-05-03|1994-08-30|Dermagraphics, Inc.|Inserting device for a barbed tissue connector|

---

US5344415A|1993-06-15|1994-09-06|Deroyal Industries, Inc.|Sterile system for dressing vascular access site|

---

US5437651A|1993-09-01|1995-08-01|Research Medical, Inc.|Medical suction apparatus|

---

US5549584A|1994-02-14|1996-08-27|The Kendall Company|Apparatus for removing fluid from a wound|

---

US5607388A|1994-06-16|1997-03-04|Hercules Incorporated|Multi-purpose wound dressing|

---

US5556375A|1994-06-16|1996-09-17|Hercules Incorporated|Wound dressing having a fenestrated base layer|

---

US5664270A|1994-07-19|1997-09-09|Kinetic Concepts, Inc.|Patient interface system|

---

AU698477B2|1994-08-22|1998-10-29|Kci Licensing, Inc.|Wound drainage equipment|

---

DE29504378U1|1995-03-15|1995-09-14|Mtg Medizinisch Tech Geraeteba|Electronically controlled low-vacuum pump for chest and wound drainage|

---

US6024720A|1995-07-18|2000-02-15|Aquarius Medical Corporation|Fluid management system for arthroscopic surgery|

---

EP0858347B1|1995-10-20|2005-03-02|Harvest Technologies Corporation|Container with integral pump platen|

---

US7207966B2|1995-11-01|2007-04-24|Ethicon, Inc.|System for fluid retention management|

---

GB9523253D0|1995-11-14|1996-01-17|Mediscus Prod Ltd|Portable wound treatment apparatus|

---

US6135116A|1997-07-28|2000-10-24|Kci Licensing, Inc.|Therapeutic method for treating ulcers|

---

US6070761A|1997-08-22|2000-06-06|Deka Products Limited Partnership|Vial loading method and apparatus for intelligent admixture and delivery of intravenous drugs|

---

AU755496B2|1997-09-12|2002-12-12|Kci Licensing, Inc.|Surgical drape and suction head for wound treatment|

---

GB9719520D0|1997-09-12|1997-11-19|Kci Medical Ltd|Surgical drape and suction heads for wound treatment|

---

US6071267A|1998-02-06|2000-06-06|Kinetic Concepts, Inc.|Medical patient fluid management interface system and method|

---

CA2335030C|1998-06-18|2007-01-09|Medical Research Group, Inc.|Medical infusion device with a source of controlled compliance|

---

US6488643B1|1998-10-08|2002-12-03|Kci Licensing, Inc.|Wound healing foot wrap|

---

US6287316B1|1999-03-26|2001-09-11|Ethicon, Inc.|Knitted surgical mesh|

---

US6962488B2|1999-11-10|2005-11-08|Alcon, Inc.|Surgical cassette having an aspiration pressure sensor|

---

EP1233808B1|1999-11-29|2008-07-09|Hill-Rom Services, Inc.|Wound treatment apparatus|

---

WO2002024253A2|2000-09-22|2002-03-28|C.R. Bard, Inc.|Electrically powered surgical irrigator|

---

EP1257313B1|2000-02-24|2004-05-12|Venetec International, Inc.|Universal catheter anchoring system|

---

US6856821B2|2000-05-26|2005-02-15|Kci Licensing, Inc.|System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure|

---

US6991643B2|2000-12-20|2006-01-31|Usgi Medical Inc.|Multi-barbed device for retaining tissue in apposition and methods of use|

---

US6540705B2|2001-02-22|2003-04-01|Core Products International, Inc.|Ankle brace providing upper and lower ankle adjustment|

---

US7799004B2|2001-03-05|2010-09-21|Kci Licensing, Inc.|Negative pressure wound treatment apparatus and infection identification system and method|

---

DE60223549T2|2001-07-31|2008-09-25|Scott Laboratories, Inc., Lubbock|DEVICE FOR IMPLEMENTING AN IV INFUSION|

---

US7527608B2|2002-08-12|2009-05-05|Lma North America, Inc.|Medication infusion and aspiration system and method|

---

US7846141B2|2002-09-03|2010-12-07|Bluesky Medical Group Incorporated|Reduced pressure treatment system|

---

GB0224986D0|2002-10-28|2002-12-04|Smith & Nephew|Apparatus|

---

US7976519B2|2002-12-31|2011-07-12|Kci Licensing, Inc.|Externally-applied patient interface system and method|

---

US7238010B2|2003-04-14|2007-07-03|Stryker Corporation|Surgical irrigation pump and tool system|

---

GB0325126D0|2003-10-28|2003-12-03|Smith & Nephew|Apparatus with heat|

---

GB0325120D0|2003-10-28|2003-12-03|Smith & Nephew|Apparatus with actives|

---

US7909805B2|2004-04-05|2011-03-22|Bluesky Medical Group Incorporated|Flexible reduced pressure treatment appliance|

---

US8529548B2|2004-04-27|2013-09-10|Smith & Nephew Plc|Wound treatment apparatus and method|

---

CN101478999B|2006-05-31|2012-09-05|凯利宝医疗公司|Cannula delivery apparatus and method for a disposable infusion device|

---

JP2009544398A|2006-07-24|2009-12-17|メディンゴ・リミテッド|Systems, devices and methods for fluid / drug delivery|

---

US8137314B2|2006-08-23|2012-03-20|Medtronic Minimed, Inc.|Infusion medium delivery device and method with compressible or curved reservoir or conduit|

---

BRPI0806192A2|2007-02-09|2014-01-21|Kci Licensing Inc|MANUALLY PUMPED PUMP AND METHOD TO APPLY REDUCED PRESSURE ON A FABRIC SITE|

---

US8007481B2|2008-07-17|2011-08-30|Tyco Healthcare Group Lp|Subatmospheric pressure mechanism for wound therapy system|

---

US8021347B2|2008-07-21|2011-09-20|Tyco Healthcare Group Lp|Thin film wound dressing|

---

US8216198B2|2009-01-09|2012-07-10|Tyco Healthcare Group Lp|Canister for receiving wound exudate in a negative pressure therapy system|

---

US8251979B2|2009-05-11|2012-08-28|Tyco Healthcare Group Lp|Orientation independent canister for a negative pressure wound therapy device|

---

CN103025364B|2009-07-01|2016-05-04|弗雷塞尼斯医疗保健控股公司|Delivery device and related system and method|

---

JP5727516B2|2010-01-29|2015-06-03|ケーシーアイ ライセンシング インク|Pump cassette and wound treatment apparatus|

---

US20120130341A1|2010-11-19|2012-05-24|Carefusion 303, Inc.|Combined iv bag and pump system and method|

---

JP2012187365A|2011-03-11|2012-10-04|Aquatech:Kk|Tube pump for liquid medicine infusion|

---

US9333286B2|2011-05-12|2016-05-10|Fresenius Medical Care Holdings, Inc.|Medical tubing installation detection|DE102013226713A1|2013-12-19|2015-06-25|Paul Hartmann Ag|System for combined vacuum and instillation treatment of wounds|

---

WO2015191824A2|2014-06-13|2015-12-17|The Procter & Gamble Company|Apparatus and methods for modifying keratinous surfaces|

---

US11116302B2|2015-06-11|2021-09-14|The Procter & Gamble Company|Apparatus and methods for modifying keratinous surfaces|

---

JP6796493B2|2014-06-13|2020-12-09|ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ|Equipment and methods for modifying the keratinous surface|

---

CN111280770A|2014-06-13|2020-06-16|宝洁公司|Apparatus and method for modifying keratinous surfaces|

---

EP3154392B1|2014-06-13|2020-03-18|The Procter and Gamble Company|Cartridges for the deposition of treatment compositions on keratinous surfaces|

---

US9949552B2|2014-07-25|2018-04-24|The Procter & Gamble Company|Handheld treatment apparatus for modifying keratinous surfaces|

---

US10188193B2|2014-07-25|2019-01-29|The Procter & Gamble Company|Applicator heads for handheld treatment apparatus for modifying keratinous surfaces|

---

US10314378B2|2014-07-25|2019-06-11|The Procter & Gamble Company|Cartridge assembly for a dispensing device|

---

US11083880B2|2014-07-25|2021-08-10|The Procter & Gamble Company|Angled cartridge assembly for a dispensing device|

---

US9955769B2|2014-07-25|2018-05-01|The Procter & Gamble Company|Applicator heads for handheld treatment apparatus for modifying keratinous surfaces|

---

WO2016040520A1|2014-09-10|2016-03-17|Kci Licensing, Inc.|Therapy apparatus with integrated fluid conductors and noise attenuation|

---

CN109715229A|2016-09-20|2019-05-03|美德乐控股公司|Suction and conveying device with driving unit and connector|

---

WO2018054834A1|2016-09-20|2018-03-29|Medela Holding Ag|Device for suctioning bodily fluids and for supplying a substance|

---

WO2018172217A1|2017-03-23|2018-09-27|Medela Holding Ag|Device with a peristaltic pump unit which can be coupled|

---

USD881202S1|2017-05-08|2020-04-14|Kci Licensing, Inc.|Display screen with graphical user interface for negative pressure unit|

---

CN111565769A|2017-12-20|2020-08-21|凯希特许有限公司|Combined hanger arm extension part for wound treatment device and pump cover|

---

USD886648S1|2018-04-12|2020-06-09|Kci Licensing, Inc.|Cutting template|

---

USD867907S1|2018-04-12|2019-11-26|Kci Licensing, Inc.|Cutting template|

法律状态:
2019-12-24| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2021-07-13| B25A| Requested transfer of rights approved|Owner name: 3M INNOVATIVE PROPERTIES COMPANY (US) |

---

2021-08-03| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|

---

2021-10-13| B350| Update of information on the portal [chapter 15.35 patent gazette]|

---

2021-11-16| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2022-01-25| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/11/2013, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201261729926P| true| 2012-11-26|2012-11-26|

---

US61/729,926|2012-11-26|

---

PCT/US2013/071455|WO2014082003A1|2012-11-26|2013-11-22|Combined solution pump and storage system for use with a reduced-pressure treatment system|

---